Delivery Order SPE2DB22D3004-SPE2DB25FPM46

Award Date 2/11/25
Potential Completion Date 2/12/25
Potential Value $2.6K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a Delivery Order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,927.13, is for the provision of Ceftriaxone 1 GM-D5W Bags, a critical pharmaceutical product used in medical treatment. The contract has a period of performance through January 29, 2025 and utilizes a Firm Fixed Price pricing structure. This Delivery Order is part of a larger Indefinite...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the supply of Ceftriaxone 1 GM-D5W bags. The contract has a ceiling value of $2,825.09 and is a firm fixed price arrangement. The period of performance runs through August 7, 2024. This delivery order is issued under an Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at up to $999,999,999 through December 2025, for providing...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,898.70, is for the delivery of Ceftriaxone 1 GM-D5W bags, a generic antibiotic medication used to treat a variety of bacterial infections. The contract is a Firm Fixed Price delivery order, with a completion date of July 14, 2022. This award is a part of a larger Indefinite Delivery...
This is a delivery order under an Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,521.18 firm fixed-price contract is for the delivery of Ceftriaxone 2 GM-D5W bags, a critical medical commodity used in military and federal healthcare programs. The IDC with DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, serves as the...
The federal government awarded a delivery order contract to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ceftriaxone 2 GM-D5W bags. The contract, valued at $3,085.13, is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA). This contract is part of a larger Indefinite Delivery Contract (IDC) between AmerisourceBergen and the DLA, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of Ceftriaxone 1 GM-D5W Bags, a critical antibiotic medication, with a ceiling value of $1,582.36. The contract is a firm fixed-price delivery order with a completion date of November 21, 2024. AmerisourceBergen, a for-profit organization registered in the System...
This federal contract award is for the delivery of Ceftriaxone 1 GM-D5W bags to the Defense Logistics Agency (DLA). The $1,378.25 firm fixed-price delivery order was awarded to the prime contractor, Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of October 28, 2024 and was awarded on October 27, 2024. This delivery order is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by...
This is a delivery order under a larger Indefinite Delivery Contract (IDC) awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor. The contract provides a comprehensive range of pharmaceutical products and medical supplies, including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits, to support military healthcare programs globally. The specific order is for Ceftriaxone 1...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the delivery of ceftriaxone 2 GM-D5W bags. The firm-fixed-price delivery order, valued at $1,461.92, has an ultimate completion date of August 14, 2024. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026, which serves as a primary...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation. The contract, valued at $1,458.03, is for the delivery of 4,564,139,523 units of Ceftriaxone 1 GM-D5W bags. The delivery order is part of a larger indefinite delivery contract (IDC) with a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the primary contract vehicle for...
  • SPE2DB22D3004
    Indefinite Delivery Contract
  • SPE2DB22D3004-SPE2DB25FPM46
    Delivery Order

This is a delivery order awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of Ceftriaxone 1 GM-D5W bags. The award, valued at $2,566.15, is a firm fixed-price contract with a period of performance ending on February 12, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. This particular award does not have a set-aside designation, indicating open competition.

Generated 5/13/25, 9:48 AM